Urologic Oncology Research
The University of Michigan Medical School Department of Urology Division of Urologic Oncology, in collaboration with the Rogel Cancer Center, is leading groundbreaking research in prostate, bladder, and cancer survivorship.
Our experts are dedicated to advancing innovative treatments, improving early detection, and enhancing the quality of life for patients during and after cancer treatment. From investigating cancer metastasis to pioneering survivorship programs, we are committed to shaping the future of urologic cancer care through cutting-edge discoveries and patient-centered initiatives.
Prostate Cancer Research
The Urologic Oncology Division is at the forefront of advancing innovative and collaborative explorations in the field of prostate cancer research. This is accomplished thanks to a broad range of research laboratories and grant funding.
As a part of the renowned U-M Rogel Cancer Center, the Urologic Oncology team has a wide range of resources as its disposal to foster class-leading research. This is highlighted by the Specialized Program of Research Excellence (SPORE) grant in prostate cancer, a PO1 in prostate cancer metastasis to bone, a National Cancer Institute T32 Urology training grant focused on urologic oncology and much more.
Bladder Cancer Research
The U-M Rogel Cancer Center and Urologic Oncology Division is dedicated to bladder cancer research and discovery. Our physicians and other scientists work to develop new and better methods to detect and treat bladder cancer. Our goal is to improve our patients’ quality and length of life.
Cancer Survivorship Research
Support for urologic oncology patients does not stop once the disease is controlled. The Division of Urologic Oncology is at the forefront of the field of Urology in working with cancer survivors to maintain their quality of life after successful cancer treatment. This work includes support for patients, partners and families, as well as cutting edge research in cancer survivorship.
Overview
Cancer survivorship research at in the Urologic Oncology Division examines the critical and often unmet needs of urologic cancer survivors, such as inadequate preparation for physical and emotional changes after surgical prostate cancer treatment, the couples’ recovery of sexual intimacy and self-management of treatment-related side-effects. In engaging in this kind of research, the investigators aim to protect and enhance survivors’ quality of life after treatment.
The urologic oncology team within the U-M Department of Urology is setting the standard for research in the field of prostate cancer survivorship. Having secured grant-support and developed partnerships and collaborations, the Department of Urology is regarded highly as a leader in cancer survivorship research nationally and internationally.
Prostate Cancer Survivorship Initiative
The Brandon Prostate Cancer Survivorship Program at the Rogel Cancer Center offers automatic enrollment for new patients. It provides personalized support to help manage treatment side effects and enhance recovery. The program focuses on screening, urinary and sexual health, and mental well-being.
